PharmaHungary 2000 Ltd.
PharmaHungary 2000 Ltd is a preclinical and clinical research and marketing
organization, a University Spin-off Company. The mission of PharmaHungary
is to develop, patent, and market new technologies in the pharmaceutical
and clinical chemistry fields for the diagnosis and therapy of
cardiovascular, allergic, and inflammatory diseases.
The company focuses on
the development of new compounds that inhibit the actions of the toxic
substance peroxynitrite and its downstream cellular targets. Pharmahungary
intends to license its new technologies to larger pharmaceutical and
biotechnological companies and to develop joint venture R&D project.
In
addition to the development of innovative technologies, PharmaHungary
provides preclinical and clinical pharmaceutical research, development, and
marketing services for the pharmaceutical, biotechnological, and food
supplement industry. The high quality of the services of PharmaHungary is
based on our highly trained management team with recognized international
expertise in preclinical and clinical pharmacology as well as medical
science and marketing management.
For further details visit
www.pharmahungary.com
